ADAR1 Capital Management »

Jasper Therapeuritc shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Jasper Therapeuritc (JSPR) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Jasper Therapeuritc

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeuritc held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeuritc by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $71k 2.4k 29.36

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Jasper Therapeuritc

Velan Capital Investment Management
Soleus Capital Management
Carlyle
Qiming U.S. Ventures Management
Avidity Partners Management
Franklin Resources
BlackRock
Vanguard Group
Samsara BioCapital
Kingdon Capital Management
Sphera Funds Management
Woodline Partners
Rock Springs Capital Management
Dr. Jeffrey R. Jay, M.D.
Opaleye Management

View all funds holding Jasper Therapeuritc